Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Probiotics in Neovascular AMD
NCT05604989Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2023
- Primary completion
- Aug 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of The Perfect Probiotics in neovascular age-related macular degeneration (NVAMD), sponsored by Seoul National University Bundang Hospital. Started Jan 2023; status: completed.
02
Drugs
The Perfect Probiotics
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT05604989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05604989.